We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,227
Increased
3,693
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TDSC icon
7551
Exchange Listed Funds Trust ETC Cabana Target Drawdown 10 ETF
TDSC
$103M
$13.1K ﹤0.01%
539
-352
-40% -$8.42K
MTEN
7552
Mingteng International Corp
MTEN
$6.89M
$13K ﹤0.01%
+23
New +$23.4K
UPC icon
7553
Universe Pharmaceuticals Inc
UPC
$3.99M
$13K ﹤0.01%
9
+7
+350% +$9.71K
INTE
7554
DELISTED
Integral Acquisition Corporation 1 Class A Common Stock
INTE
$13K ﹤0.01%
1,186
-848
-42% -$9.25K
BVFL icon
7555
BV Financial
BVFL
$183M
$13K ﹤0.01%
1,090
-497
-31% -$5.37K
ICCC icon
7556
ImmuCell
ICCC
$97.3M
$13K ﹤0.01%
2,675
-1,775
-40% -$8.54K
GLDI icon
7557
Credit Suisse X-Links Gold Shares Covered Call ETNs due February 2 2033
GLDI
$32.1M
$13K ﹤0.01%
+88
New +$13.2K
GNLN icon
7558
Greenlane Holdings
GNLN
$1.23M
$12.9K ﹤0.01%
+1
New +$35.6K
OVF icon
7559
Overlay Shares Foreign Equity ETF
OVF
$52.6M
$12.9K ﹤0.01%
519
+425
+452% +$10.4K
QXO
7560
QXO Inc
QXO
$16.5B
$12.9K ﹤0.01%
180
-231
-56% -$28.3K
EVSB icon
7561
Eaton Vance Ultra-Short Income ETF
EVSB
$244M
$12.9K ﹤0.01%
256
+193
+306% +$9.75K
BJAN icon
7562
Innovator US Equity Buffer ETF January
BJAN
$348M
$12.9K ﹤0.01%
286
-696
-71% -$30.5K
LSTA icon
7563
Lisata Therapeutics
LSTA
$10.2M
$12.9K ﹤0.01%
3,709
+3,708
+370,800% +$11.3K
LSDI
7564
DELISTED
Lucy Scientific Discovery Inc. Common Stock
LSDI
$12.8K ﹤0.01%
24,986
+23,989
+2,406% +$22.7K
OESX icon
7565
Orion Energy Systems
OESX
$65.1M
$12.8K ﹤0.01%
1,152
-217
-16% -$2.12K
CRIS icon
7566
Curis
CRIS
$8.85M
$12.7K ﹤0.01%
92
+36
+64% +$8.96K
DFSB icon
7567
Dimensional Global Sustainability Fixed Income ETF
DFSB
$731M
$12.7K ﹤0.01%
+249
New +$12.7K
ABEO icon
7568
Abeona Therapeutics
ABEO
$388M
$12.7K ﹤0.01%
3,000
-7,457
-71% -$38K
PIII icon
7569
P3 Health Partners
PIII
$33.8M
$12.7K ﹤0.01%
563
-345
-38% -$10.3K
FBOT icon
7570
Fidelity Disruptive Automation ETF
FBOT
$221M
$12.7K ﹤0.01%
478
+407
+573% +$10.6K
DCMT icon
7571
DoubleLine Commodity Strategy ETF
DCMT
$39.3M
$12.7K ﹤0.01%
492
-1,253
-72% -$32.7K
GCC icon
7572
WisdomTree Enhanced Commodity Strategy Fund
GCC
$271M
$12.6K ﹤0.01%
+669
New +$12.8K
OKLO
7573
Oklo
OKLO
$7.48B
$12.6K ﹤0.01%
1,490
+1,469
+6,995% +$16.5K
SVMH
7574
DELISTED
SRIVARU Holding Limited Ordinary Shares
SVMH
$12.6K ﹤0.01%
1,417
+1,350
+2,015% +$12.5K
SGE
7575
DELISTED
Strong Global Entertainment, Inc.
SGE
$12.6K ﹤0.01%
+8,187
New +$12.3K

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,227 new, 3,693 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,227 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.